NDC 70934-590
Levothyroxine Sodium 0.137 mg tablet
On the label: Denton Pharma, Inc. DBA Northwind Pharmaceuticals.. It's repackaged: Denton Pharma, Inc. DBA Northwind Pharmaceuticals. rebottles it from Lupin Pharmaceuticals, Inc.'s NDC 68180-972.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Lupin Limited | Dhar, India | Makes it and packages it | Problems found, fixed voluntarilySep 27, 2024 · 4 inspections |
Repackaging site
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals, Location not on file · repackages it
Recalls
- Dec 20, 2024 · Class II · Lupin Pharmaceuticals Inc.
Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
Lots: Lot# LA01276, Exp Date: 07/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Levothyroxine: every company that makes it
- Form
- tablet
- Strength
- 0.137 mg
- Approval
- ANDA ANDA209713
- On the market since
- Feb 24, 2020
- Package NDCs
70934-590-30- Official label
- DailyMed (National Library of Medicine), updated Feb 24, 2020
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?